XIAOFANG INGRAM: Open Payments
NPI 1912604737 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $136 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Alkermes, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Braeburn Inc. | 1 | $23 |
| Corium, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: FANAPT, ARISTADA, CAPLYTA, BRIXADI, Azstarys, REXULTI.
Industry payments across VA — which companies pay providers there.
